摘要
目的：研究糖尿病终末期肾病（ＥＳＲＤ）患者的透析治疗，选择血液透析（ＨＤ）好还是持续性非卧床腹膜透析（ＣＡＰＤ）好。方法：观察了６８例接受透析治疗的糖尿病ＥＳＲＤ患者，其中５２例进行ＨＤ治疗，１６例进行ＣＡＰＤ治疗。对比两组患者透析前后的血液生化指标、生存率、死亡原因、血糖的控制、透析后主要并发症。结果：６０岁以下ＨＤ或ＣＡＰＤ治疗患者３年生存率均达７５％以上。但透析前合并有高血压、心脏肥大、冠心病或年龄大于６０岁者，行ＣＡＰＤ治疗后出现并发症的机会较ＨＤ少。结论：透析前合并有高血压、心脏肥大、冠心病或年龄大于６０岁的糖尿病ＥＳＲＤ患者以选择ＣＡＰＤ治疗较佳。
OBJECTIVE To find out the better mode of dialysis in diabetic patients, the outcome of patients treated by hemodialysis(HD) and continuous ambulatory peritoneal dialysis (CAPD) have been compared in this study. METHODOLOGY Sixty eight patients of diabetic nephropathy with ESRD were enrolled in this study, fifty two patients treated by HD and sixteen by CAPD. The average time of dialysis treatment was 16 5±12 3 months in HD group and 16 3±13 3 months in CAPD group. Biochemical parameters, blood pressure, residual renal function, survival rates, causes of death, control of diabetes, complication were compared between the two groups. RESULTS In diabetic patients under 60 years of age treated by either HD or CAPD, the survival rate at three years of treatment was over 75%. In patients over 60 years or with hypertension or coronary heart disease, complication during dialysis treatment was found to be less frequent in CAPD patients than in HD patients. CONCLUSION CAPD has a better therapeutic effect for diabetics with ESRD who are over 60 years old, especially in patients with hypertension or coronary heart disease.
出处
《肾脏病与透析肾移植杂志》
CAS
CSCD
1997年第4期314-318,共5页
Chinese Journal of Nephrology,Dialysis & Transplantation
关键词
糖尿病肾病
血液透析
持续性
非卧床腹膜透析
hemodialysis continuous ambulatory peritoneal dialysis diabetic nephropathy
